AVGO vs BCRX Stock Comparison

BCRX currently leads AVGO in this stock comparison, with AIQ scores of 59 vs 52. The clearest difference is value, while AVGO has the stronger quality profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 7 points
AVGO
Technology
vs
BCRX
Healthcare
AVGO
Broadcom Inc.
Price
$347
Day move
-4.76%
AIQ Score
52/100
Best edge
Quality
Sector
Technology
BCRX
BioCryst Pharmaceuticals, Inc.
Leads
Price
$7.61
Day move
-0.91%
AIQ Score
59/100
Best edge
Value
Sector
Healthcare

What is the main difference between AVGO and BCRX?

BCRX leads the current stock comparison as BioCryst Pharmaceuticals, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Broadcom Inc. vs BioCryst Pharmaceuticals, Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Technology vs Healthcare· Coverage 65/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 5/10

BCRX leads

BCRX leads by 7 AIQ points, primarily on Value and Risk Resilience. Wall Street currently favors AVGO on target upside.

Competitive: 3 of 6 evidence groups support BCRX.

Evidence agreement: 3 of 6Comparison trend: Stable
AVGO

Broadcom Inc.

AIQ Score
52/100
AIQ Edge Score
7/10
BCRX

BioCryst Pharmaceuticals, Inc.

Leads
AIQ Score
59/100
AIQ Edge Score
6/10

The Algovestiq AIQ Score currently favors BCRX over AVGO, 59 versus 52 as of Nov 15, 2026. BCRX's advantage is driven primarily by stronger value and risk resilience, while AVGO holds the stronger quality profile. BCRX also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors AVGO. 3 of 6 covered evidence groups favor BCRX today, and the comparison is rated Competitive on stability: only 3 of 6 covered evidence groups agree. BCRX lead: Stable — the AIQ differential has held near 7 points over 30 sessions.

Compare Broadcom Inc. and BioCryst Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

AVGO
+565.5%
BCRX
-36.6%

Total return comparison

Growth of $10,000, distributions reinvested

AVGO $66,548 · BCRX $6,336

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare AVGO and BCRX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

AVGO advantage
0
BCRX advantage
  • Value50 vs 86
    BCRX +36
  • Risk Resilience47 vs 55
    BCRX +8
  • Quality69 vs 64
    AVGO +5
  • Momentum40 vs 42
    Even

3 of 6 evidence groups favor BCRX. BCRX’s edge is concentrated in value and risk resilience; AVGO keeps a meaningful quality edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

AVGO0 AIQ

Largest factor move: Momentum -2, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 6 active signals are unchanged.

BCRX0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 4 active signals are unchanged.

BCRX's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — AVGO and BCRX both carry a full feed there.

The central trade-off

BCRX (BioCryst Pharmaceuticals, Inc.): the stronger current systematic profile, led by value and risk resilience.

AVGO (Broadcom Inc.): the counter-case, on quality, fundamentals, technicals — but at materially higher volatility, 70% against 45.2%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BCRX

BCRX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AVGO

AVGO on combined revenue and EPS growth.

Value

BCRX

BCRX on the peer-relative Value factor, by 36 points.

Momentum

Even

The two are level on Momentum.

Lower downside

BCRX

BCRX on Risk Resilience, by 8 points.

Analyst upside

AVGO

AVGO on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors BCRX, analyst targets favor AVGO. That disagreement is the most useful thing on this page.

MeasureAVGOBCRXNote
Implied upside to target+48.5%+44.5%AVGO has more room
Target dispersion+48.5%0%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering5111Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor BCRX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreBCRX52 vs 59
FundamentalsAVGOrevenue growth 33.4% vs -17.4%; EPS growth 40.3% vs -51.6%; TTM ROE 13.1% vs -9.5%; gross margin 68.8% vs 25.3%; operating margin 48.4% vs -30.1%
ValuationBCRXValue 50 vs 86
TechnicalsAVGOPrice vs 50-day 0.5% vs -7.6%; vs 200-day -5.6% vs -13.5%
Risk ResilienceBCRXRisk Resilience 47 vs 55
Analyst expectationsAVGOTarget upside 48.5% vs 44.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and BCRX and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is moderate at 7 points.
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BCRX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

BCRX lead: Stable — the AIQ differential has held near 7 points over 30 sessions.

May 27AVGO leads above the line · BCRX leads belowNov 13
Today
BCRX +7
52 vs 59
7 sessions ago
BCRX +12
50 vs 62
30 sessions ago
BCRX +5
55 vs 60
90 sessions ago
BCRX +12
59 vs 71

The lead changed hands once in this window, most recently on Sep 29 when AVGO moved ahead of BCRX.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

AVGOConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only AVGO

  • Accumulation Pattern — bullish, volume, medium horizon (1.18x)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
BCRX

0 bullish / 2 bearish / 2 neutral

Only BCRX

  • Downtrend Structure Active — bearish, trend, long horizon

Both carry 3 more signals that do not separate them: Death Cross Active, ADX Trend Weakening, ATR Expansion - Breakout Mode.

AVGO is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

AVGONo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -4.76%, AIQ 0 points).

BCRXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.91%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1AVGO closes the Value gap — currently 36 points behind, the largest single contributor to BCRX's edge.
  2. 2AVGO's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3BCRX starts generating bearish momentum or trend signals.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AVGO leads on balance
MetricAVGOBCRX
Revenue growth (YoY)33.4%-17.4%
EPS growth (YoY)40.3%-51.6%
Gross margin68.8%25.3%
Operating margin48.4%-30.1%
Return on equity (TTM)13.1%-9.5%
Debt to equity0.6-2.08

Performance

AVGO leads 4 of 6 windows
MetricAVGOBCRX
1 week (5 sessions)18.2%-1%
1 month (20 sessions)5.6%-2.3%
3 months (63 sessions)-11.6%-23.4%
6 months (126 sessions)-18.4%-15.6%
Year to date0.3%-2.4%
1 year (252 sessions)-2.3%6%

Technicals

AVGO has the stronger structure
MetricAVGOBCRX
RSI (14)53.240.7
ADX (14)2315.2
Price vs 50-day0.5%-7.6%
Price vs 200-day-5.6%-13.5%
Volatility (1M, annualized)70%45.2%

Risk

BCRX is the more resilient
MetricAVGOBCRX
Beta2.210.65
Sharpe ratio0.210.36
Sortino ratio0.290.56
Max drawdown-39.5%-32.2%
Current drawdown-27.9%-31.5%
Annualized volatility48.6%48.1%
Value at risk (95%)-4.6%-4.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, AVGO or BCRX?

On the Algovestiq AIQ Score, BCRX is the stronger of the two as of Nov 15, 2026, scoring 59 against AVGO's 52. The edge comes from value and risk resilience. AVGO is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is AVGO or BCRX the better buy right now?

BCRX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor BCRX over AVGO?

The composite weights Quality, Value, Momentum and Risk Resilience. BCRX leads Value by 36 points; BCRX leads Risk Resilience by 8 points; AVGO leads Quality by 5 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, AVGO or BCRX?

Analyst price targets imply +48.5% upside for AVGO and +44.5% for BCRX, so the Street currently favors AVGO. That points the opposite way to the AIQ Score, which favors BCRX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, AVGO or BCRX?

BCRX is the better-valued of the two on the peer-relative Value factor. BCRX on the peer-relative Value factor, by 36 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, AVGO or BCRX?

AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, AVGO or BCRX?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, AVGO or BCRX?

BCRX is the more resilient of the two, so the other name carries the higher downside risk. BCRX on Risk Resilience, by 8 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is AVGO more profitable than BCRX?

AVGO leads on the comparable margin measures — gross margin 68.8% vs 25.3%; operating margin 48.4% vs -30.1%; ttm roe 13.1% vs -9.5%.

Is BCRX's lead over AVGO getting stronger or weaker?

BCRX lead: Stable — the AIQ differential has held near 7 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-09-29, when AVGO moved ahead of BCRX.

What would change the AVGO vs BCRX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Value gap — currently 36 points behind, the largest single contributor to BCRX's edge; AVGO's Death Cross Active resolves — a bearish trend rule currently active against it; BCRX starts generating bearish momentum or trend signals; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about AVGO and BCRX?

AVGO: 2 bullish / 2 bearish / 2 neutral, conflicted. BCRX: 0 bullish / 2 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On BCRX it is Death Cross Active (bearish, long horizon).

Compare AVGO and BCRX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.